Clinical Trial Update: A Study of Tarlatamab for People With Prostate Cancer [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 trial of tarlatamab for metastatic prostate cancer, noting that the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Tarlatamab

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Metastatic Prostate Cancer | Phase 2 | Status: RECRUITING